Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer
Previously, based on a DNA microarray experiment, we identified a 96-gene prognostic signature associated with the shorter survival of ovarian cancer patients. We hypothesized that some differentially expressed protein-coding genes from this signature could potentially serve as prognostic markers. T...
Main Authors: | Katarzyna Aleksandra Kujawa, Ewa Zembala-Nożyńska, Alexander Jorge Cortez, Tomasz Kujawa, Jolanta Kupryjańczyk, Katarzyna Marta Lisowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/1/149 |
Similar Items
-
Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8
by: Patrycja Tudrej, et al.
Published: (2018-07-01) -
TGF-β (BETA) AND PERIOSTIN MODULATE EACH OTHER’S EXPRESSION IN BOTH BREAST STROMA AND TUMOR CELLS
by: Das Burman, Anindita
Published: (2013) -
Diagnostic value of E-cadherin and fibronectin in differentiation between reactive mesothelial and adenocarcinoma cells in serous effusions
by: Noushin Afshar Moghaddam, et al.
Published: (2012-01-01) -
Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
by: Se Ik Kim, et al.
Published: (2020-03-01) -
Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions
by: Agarwal Chetna, et al.
Published: (2009-01-01)